Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study

Colao, Annamaria; D. Bronstein, Marcello; U. Freda, Pamela; Gu, Feng; Shen, Chiung‐Chyi; R. Gadelha, Mônica; Fleseriu, Maria; J. van der Lely, A.; J. Farrall, Andrew; Hermosillo Reséndiz, Karina; Ruffin, Matthieu; Chen, Yixin; N. Sheppard, Mary; behalf of the Pasireotide C2305 Study Group, on

doi:10.1210/jc.2013-2480

Public

Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study

Published in The Journal of Clinical Endocrinology & Metabolism • Jan 14, 2014

Authors:

Annamaria Colao

Marcello D. Bronstein

Pamela U. Freda

Abstract

CONTEXT: Biochemical control reduces morbidity and increases life expectancy in patients with acromegaly. With current medical therapies, including the gold standard octreotide long-acting-release (LAR), many patients do not achieve biochemical control. OBJECTIVE: Our objective was to demonstrate th...

Subject

Acromegaly

Pasireotide

Octreotide

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!